Publication

Article

Pharmacy Times

June 2014 Women's Health
Volume80
Issue 6

Women Underestimate Risk of Lung Cancer

Responses from a survey conducted by the American Lung Association reveal that most women believe that breast cancer is the number 1 cancer killer of women, although lung cancer has caused more deaths among women for more than 25 years. The Women’s Lung Health Barometer surveyed more than 1000 American women 18 years and older about their perceptions of lung cancer. Their responses indicated that most women were misinformed about the disease and few were concerned about their risk.

When asked to identify the top cancer killer of women from a list of cancers, only 22% of women chose lung cancer, while 51% chose breast cancer. In addition, 58% of women claimed to be knowledgeable about lung cancer, but in reality, many did not know key facts about the disease. Many women indicated that they thought lung cancer was only a risk for smokers, and 49% said they were not concerned about developing the disease because they had quit smoking or had never smoked. Younger women were more likely to be misinformed about the disease than older women. Among those aged 18 to 35 years, 60% were not concerned about lung cancer because they did not smoke, compared with 46% of women belonging to Generation X and 40% of baby boomers.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com